The expression of several cytokines and adhesion molecules is regulated by the transcription factor NFB, which is activated by tumor necrosis factor alpha (TNF-␣). In this study, we employed a mouse model of nephritis induced by TNF-␣ to examine whether inhibition of NFB activity using transcription factor decoy oligonucleotides (ODN) blocks cytokine and adhesion molecule expression and attenuates the renal inflammatory response. First, we developed a method for delivering FITC-ODN in vivo into mouse kidney glomeruli by employing HVJ-liposome. Then, in order to study the feasibility of decoy strategy in vivo, the reporter gene chloramphenicol acetyltransferase (CAT) driven by three tandemly repeated NFB binding sequences was transfected into the kidney. Intrapenetorial injection of TNF-␣
Introduction
The response to glomerular injury is characterized by the expression of cytokines and adhesion molecules mediating a local inflammatory process.
1 Interleukin (IL)-1, 2, 6 and 8, intracellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) are up-regulated in glomerulonephritis. [1] [2] [3] [4] [5] [6] [7] Therefore, the process of glomerular injury has been postulated to be dependent on the coordinated activation of a series of cytokine and adhesion molecule genes that results in the adhesion of leukocytes and release of cytotoxic molecules. A critical element in the regulation of these genes involves the complex formed by NFB and IB. [8] [9] [10] [11] [12] Dissociation of the transcription factor NFB from this complex is proposed to play a pivotal role in the regulation of glomerular changes by inducing a coordinated transactivation of genes involved in these processes including IL-1, 6, 8, ICAM-1, VCAM-1 and endothelial-leukocyte adhesion molecule (ELAM), to name a few. [1] [2] [3] [4] [5] [6] [7] Thus, we hypothesized that interference of NFB interaction with stimulated CAT expression in vivo, and the increase in CAT expression was completely abolished by NFB decoy ODN, but not scrambled ODN. Therefore, we examined the effect of NFB decoy ODN transfection on TNF-␣-induced endogenous interleukin (IL)-1␣, IL-1␤, IL-6, ICAM-1 and VCAM-1 gene expression as assessed by RT-PCR and Northern blotting. Our present data showed that NFB decoy, but not scrambled, ODN abolished TNF-␣ induced gene expression in vivo, as well as glomerular inflammation as assessed by CD45 staining. Taken together, our results suggest the potential utility of NFB decoy strategy for molecular therapy to glomerular inflammatory diseases. Gene Therapy (2000) 7, 1326-1332.
its cis element in the promoter region of these genes can inhibit the inflammatory response underlying glomerulonephritis. Transcription factor decoy (TFD) has been shown to be an effective strategy for inhibiting gene transcription both in vitro and in vivo. [13] [14] [15] [16] [17] [18] In this study, we examined in vivo efficacy of TFD oligonucleotides (ODN) to NFB in treating a murine model of glomerular inflammation induced by TNF-␣. This study demonstrates the feasibility of the decoy strategy in the treatment of glomerulonephritis. We employed the HVJliposome technique which has been reported to be useful for kidney gene transfer 19, 20 and documented its relative efficiency for ODN transfer into the mouse glomeruli in vivo. TFD ODN to NFB were transfected into the kidneys of mice injected with TNF-␣, and documented that NFB decoy, but not scrambled, ODN blocked TNF-␣-induced expressions of IL-1 and IL-6, ICAM-1 and VCAM-1 as well as attenuated the inflammatory cell infiltration in the mouse glomeruli in vivo.
Results
First, we performed gel mobility shift assay to confirm the binding of NFB decoy ODN to the specific nuclear protein from mouse kidneys. As shown in Figure 1 , TNF-␣ injection induced an increase of NFB binding protein in mouse glomerular nuclear extract. Furthermore, NFB ODN at 100-and 200-fold excess competed effectively with the NFB binding site for binding to NFB. On the other hand, scrambled ODN did not compete at 100-and 200-excess concentration.
Next, we examined the efficacy of HVJ-liposome mediated ODN transfer into the mouse kidney in vivo. We intrarenally infused FITC-labeled ODN and studied the cellular localization and pharmacokinetics. As shown in Figure 2 renal infusion of free FITC (not binding to ODN) did not result in any specific fluorescence in glomerular cells.
We initially utilized the reporter gene to document the NFB decoy ODN effectiveness in vivo. Cotransfection of NFB decoy ODN and CAT reporter plasmid driven by the NFB binding site in the promoter region was examined. As shown in Figure 3 , cotransfection of NFB decoy ODN markedly attenuated TNF-␣-stimulated CAT gene expression, whereas cotransfection of scrambled ODN did not. Moreover, transfection of AP-1 decoy ODN was also performed to show the specific effect of NFB decoy ODN. As shown in Figure 3 , there was no significant inhibitory effect on CAT gene expression by AP-1 decoy ODN.
Therefore, we assessed the effect of NFB decoy ODN on the endogenous cytokine gene expressions in the mouse kidney in vivo. As shown in Figure 4a , TNF-␣ stimulated the expression of IL-1␣, IL-1␤ and IL-6 mRNA in the kidney. In vivo transfection of NFB decoy, but not scrambled, ODN resulted in the attenuation of TNF-␣-induced cytokine (IL-1␣, IL-1␤ and IL-6) mRNA expression in the glomeruli as assessed by RT-PCR,
Figure 3 Effect of decoy NFB ODN on in vivo kidney CAT expression. Mice were cotransfected via the renal artery with decoy ODN and CAT expression vector and were administered with TNF-␣ (100 ng/ml, i.p.). Three days after transfection, cell lysate were prepared from kidneys of the mice treated with scrambled ODN (SD), AP-1 decoy ODN (AP-1)
or NFB decoy ODN (NFB) and CAT activity was measured. *P Ͻ 0.01 versus SD.
Figure 4 Effect of NFB decoy ODN on renal mRNA expression of cytokines. RNA was prepared from kidneys of untreated mice (lane 1), kidneys of TNF-␣ (100 ng/ml, i.p.) administered mice which were transfected with scrambled ODN (lane 2) or NFB decoy ODN (lane 3). IL-1␣, IL-1␤, IL-6 and ICAM-1 (a), and VCAM-1 and TGF-␤ (b) mRNA expression were analyzed by RT-PCR. Lane 4, amplification without RNA (negative control).
whereas ␤-actin mRNA expression was not affected. Moreover, an inhibitory effect of NFB decoy ODN on the TNF-␣-mediated adhesion molecule (ICAM-1 and VCAM-1) gene expression was also demonstrated ( Figure  4a and b). In contrast, the mRNA level of TGF-␤, which does not have NFB binding sites in its promoter region, was not affected by NFB decoy ODN transfection ( Figure 4b ). Inhibition of IL-6 and ICAM-1 mRNA expression was also examined by Northern blotting. As shown in Figure 5 , mRNA of IL-6 and ICAM-1 was decreased by transfection of NFB decoy ODN, while TNF-␣ stimulated mRNA expression of IL-6 and ICAM-1. In contrast, G3PDH mRNA expression was not affected by the transfection of NFB decoy ODN.
Finally, the effect of NFB decoy ODN on the renal inflammatory changes in response to TNF-␣ was evaluated by examining leukocyte common antigen, CD45 staining in the glomeruli, given with the significant decrease in the levels of adhesion molecules. As was expected, TNF-␣ increased the number of CD45 positive cells in the glomeruli at 3 days after injection. As shown in Figure 6 , NFB decoy ODN transfection attenuated the number of CD45 positive cells in the glomeruli. In contrast, scrambled ODN transfection did not affect the number of CD45 positive cells. Quantitative analysis was performed on five mice in each group as shown in Figure  7 . No evidence of cytotoxicity of inflammation caused by HVJ-liposome complex was observed in mice (data not shown).
Discussion
The pathogenesis of glomerulonephritis is incompletely understood. The initiating factor is generally thought to be some form of injury to mesangial and other resident cells in the glomerulus. The response to glomerular injury include mesangiolysis, mesangial proliferation, inflammatory cell infiltration and matrix expansion. Multiple growth factors and cytokines have been reported to be activated in glomerulonephritis and are believed to mediate the proliferative and inflammatory responses. 1 The transcription factor NFB regulates the expression of several cytokines and adhesion molecules (IL-1␣, IL-1␤, IL-6, IL-8, ICAM-1 and VCAM-1, to name a few) which contain in their promoter region NFB-responsive element.
8-10 Accordingly, we hypothesize that the final common pathway of NFB coordinated gene expression is an ideal target for the molecular therapy of glomerular inflammatory diseases. The cytokine TNF-␣ induces IL-1␣, IL-1␤, IL-6, IL-8, ICAM-1 and VCAM-1 expression via the activation of NFB. [8] [9] [10] It has been reported that intrapenetorial injection of TNF-␣ elicits an inflammatory response in the glomeruli. Therefore, we reasoned that TNF-␣ nephritis is a useful model to evaluate the concept of molecular inhibition of NFB as a therapeutic strategy in vivo.
Synthetic double-stranded ODN as TFD can block the binding of specific nuclear factor to its corresponding cis element in the promoter regions of targeted genes, resulting in the inhibition of gene transactivation. [13] [14] [15] [16] [17] [18] To date, no reports have yet described the use of TFD ODN for in vivo molecular therapy of renal diseases. This study demonstrates the feasibility of the NFB decoy strategy in the treatment of glomerular inflammatory disease in vivo. Our data demonstrate that in vivo transfection of glomerular cells with sufficient quantities of the NFB decoy ODN results in the inhibtion of NFB to its cis element of target genes (IL-1␣, IL-1␤, IL-6, IL-8, ICAM-1 and VCAM-1), thereby preventing the transactivating of the expression of the above cytokines and adhesion molecules in vivo.
The specificity of the inhibitory effect of the decoy
Gene Therapy ODN against NFB in vivo is supported by several lines of evidence: (1) NFB decoy ODN exhibited NFBspecific protein binding as documented by gel shift assay; (2) NFB decoy ODN completely inhibited TNF-␣-mediated CAT expression that is driven by NFB binding sites, whereas the scrambled ODN and AP-1 decoy ODN did not; (3) NFB decoy ODN selectively inhibited the expression and production of the targeted cytokine genes (IL-1␣, IL-1␤ and IL-6), but not TGF-␤ and ␤-actin; and (4) NFB decoy ODN specifically inhibited the expression of the targeted adhesion molecules (ICAM-1 and VCAM-1) in vivo, whereas scrambled ODN did not. The decoy approach is particularly attractive as molecular therapy for renal diseases for several reasons: (1) the potential drug targets (ie transcription factors) are plentiful and readily identifiable; (2) the synthesis of the sequencespecific decoys is relatively simple and can be targeted to specific tissues; (3) knowledge of the exact molecular structure of the targeted transcription factor is unnecessary; and (4) decoy ODN may be more effective than antisense ODN in blocking constitutively expressed factors as well as multiple transcription factors that bind to the same cis element.
21,22
The effectiveness of ODN for the therapy for renal diseases may be limited by in vivo delivery system. Previous attempts at glomerular gene transfer in vivo using adenoviral and retroviral vectors have been unsuccessful. 23, 24 It has been reported that the adenoviral method is efficient for tubular, but not for glomerular transfection. 24 The HVJ-liposome method takes advantage of the fusigenic proteins (HN and F glycoproteins) of the HVJ viral envelope which mediate fusion with cell membrane at neutral pH. Previous studies have shown that HVJ-liposome transfer of SV40 T antigen gene, PDGF or TGF-␤ intrarenally in vivo resulted in the localization of the transgene expression in the glomerular cells. 19, 20 In this study, we have extended the use of the HVJ-liposome method to the specific transfection of ODN into the glomerulus. Our data documented that the HVJ-liposome method is more effective than direct ODN delivery in enhancing intracellular uptake and stability of ODN. Indeed, we have shown previously that the HVJ-liposome method delivers ODN directly into the cytoplasm, bypassing endocytosis. [25] [26] [27] [28] For in vivo ODN transfer into glomerular cells, we observed that it was necessary to deliver ODN by the intra-arterial route. This approach maximizes the exposoure of HVJ-liposomes to the glomerular surface as the complexes pass through the glomerulus.
In summary, we report herein a molecular therapeutic strategy to treat a model of glomerular inflammatory disease as induced by TNF-␣. Our data show that in vivo transfer of a decoy ODN binding to the critical transcription factor NFB can block the coordinated transactivation of several cytokine and adhesion molecule genes involved in the pathophysiology of nephritis. This was associated with a reduction in the glomerular inflammatory response. Further studies are necessary to determine whether the blockade of expressions of these cytokines and adhesion molecules is sufficient to prevent other forms of glomerulonephritis. Additional improvement of the ODN transfer method, as well as chemical modification of the ODN to increase their in vivo stability will be critical in enhancing therapeutic efficacy. In addition, to treat chronic diseases such as glomerulonephritis, it would clearly be necessary to administer NFB decoy ODN on a long-term basis. Our preliminary experiments showed that repeated administration up to five times of plasmid DNA and antisense ODN by the HVJ-liposome method did not result in any loss of biological effects or production of antibody against HVJ. 29, 30 However, further studies are necessary. Despite these limitations, the development of the reported strategy and technology offers promise in defining renal biological processes and for treating renal pathological conditions.
Materials and methods

Synthesis of ODN and selection of sequence targets
The sequences of phosphorothioate double-strand ODN against NFB binding site and scrambled ODN (as control) used in this study were reported previously. 11 The efficiency of binding of ODN decoy to NFB has been documented. The sequences of the phosphorothioate ODN utilized in this study were synthesized in Beckman Center (Stanford, CA, USA) and sequences are as below:
NFB decoy ODN (consensus sequences are underlined):
5Ј-CCTTGAAGGGATTTCCCTCC-3Ј 3Ј-GGAACTTCCCTAAAGGGAGG-5Ј Scrambled ODN:
5Ј-TTG CCGTACCTGACTTAGCC-3Ј 3Ј-AACGGCATGGACTGAATCGG-5Ј AP-1 decoy ODN:
5Ј-AGCTTGTGAGTCAGAAGCT-3Ј 3Ј-TCGAACACTCAGTCTTCGA-5Ј Synthetic ODN were washed by 70% ethanol, dried and dissolved in sterile Tris-EDTA buffer (10 mm Tris, 1 mm EDTA). The supernatant was purified over NAP 10 column (Pharmacia Biotech, Uppsala, Sweden) and quantitated by spectrophotometry. The single stranded ODN were annealed for 2 h while the temperature descended from 80°C to 25°C.
Gel mobility shift assay Glomeruli were isolated from the whole kidney as described previously. 31 Kidneys were removed, capsules stripped off and cortex separated from medulla. Cortex was cut into fine fragments with scissors and washed with phosphate buffered saline (PBS). To isolate the glomeruli, cortical fragments were passed through progressively smaller nylon screens (Tetko, Monterey Park, CA, USA). Nuclear extract was prepared from isolated glomeruli as described previously. 32, 33 In brief, collected glomeruli were homogenized with Potte-Elvehjem homogenizer in four volumes of ice-cold homogenization buffer (10 mm Hepes pH 7.5, 0.5 m sucrose, 0.5 mm spermidine, 0.15 mm spermin, 5 mm EDTA, 0.25 m EGTA, 7 mm ␤-mercaptoethanol, 1 mm phenylmethylsulfonylfluoride (PMSF)). After centrifugation at 12 000 g for 30 min at 4°C, the pellet was homogenized in one volume of ice-cold homogenization buffer containing 0.1% NP-40 in a Dounce homogenizer, centrifuged again at 12 000 g for 30 min at 4°C and the pellet nuclei were washed twice with ice-cold buffer containing 0.35 m sucrose. After washing, the nuclei were pre-extracted with one volume of ice-cold homogenization buffer containing 0.05 m NaCl and 10% glycerol for 15 min at 4°C, then extracted with homogenization buffer containing 0.3 m NaCl and 10% glycerol for 1 h at 4°C and the concentration of DNA was adjusted to 1 mg/ml. After pelleting the extracted nuclei at 12 000 g for 30 min at 4°C, the supernatant was brought to 45% (NH 4 ) 2 SO 4 and stirred for 30 min at 4°C. The precipitated protein were collected at 17 000 g for 30 min resuspended in homogenization buffer containing 0.35 m sucrose, and stored in aliquots at −70°C.
NFB and scrambled ODN were labeled by 3Ј endlabeling kit (Clontech, Palo Alto, CA, USA). After endlabeling, 32 P-labeled ODN probe were purified by Nick column (Pharmacia Biotech). 32 P-labeled probe (0.5-1 ng, 10 000-15 000 c.p.m.), and 1 g of polydeoxyinosinicdeoxycytidic acid (Sigma Chemical, St Louis, MO, USA) were incubated with 10 g of nuclear extract for 30 min at room temperature and then loaded on to a 5% polyacrylamide gel. The gels were subjected to electrophoresis, drying, and pre-incubated with parallel samples 10 min before the addition of the labeled probe.
Preparation of HVJ-liposomes
Phosphatidylserine, phosphatidylcholine, and cholesterol were mixed in a weight ratio of 1:4.8:2. [34] [35] [36] The lipid mixture (10 mg) was deposited on the sides of a flask by removal of tetrahydrofuran in a rotary evaporator. Dried lipid was hydrated in 200 l of balanced salt solution (BSS; 137 mm NaCl, 5.4 mm KCl, 10 mm Tris-HCl, pH 7.6) containing NFB decoy ODN or scrambled ODN. For plasmid transfection, dried lipid was hydrated in 200 l of BSS containing DNA-high mobility group (HMG)-1 complex (200 g:64 g), which had been previously incubated at 20°C for 1 h. [34] [35] [36] Liposomes were prepared by shaking and sonication. Purified HVJ (Z strain) was inactivated by UV irradiation (110 erg/mm 2 /s) for 3 min just before use. The liposome suspension (0.5 ml, containing 10 mg of lipids) was mixed with HVJ (30 000 hemagglutinating units), and filled up to 4 ml with BSS. The mixture was incubated at 4°C for 5 min and then for 1 h with gentle shaking at 37°C. Free HVJ was removed from the HVJ-liposomes by sucrose density gradient centrifugation. The top layer of sucrose gradient was collected for use.
Experimental animal protocol
Male 12-week-old C57BL/6 mice, purchased from Charles River Breeding Laboratories, were anesthetized with ketamine, and the left renal artery of each animal was surgically exposed. A cannula was introduced into the left renal artery via the aorta. In vivo ODN transfer was performed as follows: the proximal segment of the renal artery was transiently ligated and HVJ-liposome complex was infused into the renal artery over 2 min. Upon completion, the infusion cannula was removed and blood flow to the kidney was restored by release of the ligatures and the wound was then closed. One hour after ODN transfection, animals were injected with TNF-␣ (100 ng/ml) or vehicle (saline) intraperitoneally.
In vivo transfection of FITC-labeled ODN into the mouse kidney FITC-labeled phosphorothioate ODN were kindly provided by Clontech Inc. The 3Ј and 5Ј ends of the ODN (16 base pairs) were labeled with FITC using Fluorescein-ON phosphoramidite. In one group of mice (n = 8), intra-renal artery infusion of HVJ-liposome complex containing FITC-labeled phosphorothioate ODN (3 m) was performed via the left renal artery. In a second group of animals (n = 8), naked ODN (30 m) without HVJliposome was gradually infused into left renal artery. The kidneys were harvested at 1 h, 1 and 3 days after transfection and fixed with 4% paraformaldehyde. Sections were examined by fluorescent microscopy.
Cotransfection of CAT plasmid and NFB decoy ODN We examined cotransfection of CAT plasmid and decoy ODN utilizing the HVJ-liposome method. After surgical operation as described above, the HVJ-liposome complex containing 1.3 mg of lipids, 2.5 g of encapsulated plasmid DNA combined with HMG-1 and 6 m of encapsulated ODN was infused into the kidney. One hour following this, TNF-␣ (100 ng/ml) was injected intra-penetorially. Three days after transfection, the mice were killed and kidneys were removed. Kidneys were collected and lysates prepared as previously described. 31 Tissue extracts were heated at 60°C for 10 min, and the precipitate was removed by centrifugation. CAT protein content was measured using a commercial kit (Promega, Madison, WI, USA).
RNA extraction and reverse transcription (RT)-PCR At 1 day after transfection, the mice were killed and kidneys were removed. Renal RNA was extracted by RNAzol (Tel-Test, TX, USA) for RT-PCR analysis. Aliquots of RNA were amplified simultaneously by PCR and compared with a negative control (primers without RNA). The IL-1␣, IL-1␤, IL-6, TGF-␤ and ␤-actin primers were kindly donated by Clontech. The ICAM-1 and VCAM-1 primer were followed: ICAM-1 sense: 5Ј-TGACCA-TCTACAGCTTTACGGC-3Ј, ICAM-1 antisense: 5Ј-AGCCTGGCACATTGGAGTCTG-3Ј; 37 VCAM-1 sense: 5Ј-AAGGATCCGGTACCAAGCAGAGACTTG AAAT GCC-3Ј, VCAM-1 antisense: 5Ј-CCCTTGAACAGAT-CAATCT CC-3Ј. 38 Samples were amplified using the folGene Therapy lowing parameters: 94°C, 1 min; 60°C, 2 min; 72°C, 1 min for 30 cycles. Extreme care was taken to avoid contamination of tissue samples with trace amounts of experimental RNA. Amplification products were electrophoresed through 2% agarose gels stained with ethidium bromide.
Northern blot analysis
Gene expression of IL-6 and ICAM-1 was also measured by Northern blotting. For Northern blot analysis, 20 g total RNA was subjected to electrophoresis on 1.5% agarose-formaldehyde denaturing gel and transferred to a nitrocellulose membrane (Amersham International, Amersham, UK). The filter was baked, prehybridized, and hybridized to IL-6 oligonucleotides (Clontech) or full length ICAM-1 cDNA (donated by Dr Tetsuya Tomita, Osaka University Medical School) labeled by 3Јend-labeling. Then, the filter was washed and exposed to X-ray film.
Staining with CD45 for analysis of inflammation On day 3 after treatment of NFB decoy ODN animals were killed after perfusion with PBS followed by 4% paraformaldehyde. Kidneys were snap frozen. Upon fixation with cold acetone, 5 m frozen sections were stained with anti-mouse CD 45 (Pharmingen, San Diego, CA, USA) using Histostain kit (Zymed Laboratories, South San Francisco, CA, USA). The number of CD45 positive cells was counted in 15 randomly selected glomeruli from each section.
Statistical analysis
All values are expressed as mean ± s.e.m. Analysis of variance with subsequent Dunnet's test were used to determine significant differences in multiple comparisons. P Ͻ 0.05 was considered significant. All experiments were carried out at least three times.
